Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors

Details for Australian Patent Application No. 2002232760 (hide)

International Classifications

Event Publications

14 December 2006 Application Accepted

Published as AU-B-2002232760

1 March 2007 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 28 Dec 2006. Address for service in Australia - Phillips Ormonde & Fitzpatrick Level 22 367 Collins Street Melbourne VIC 3000

26 April 2007 Standard Patent Sealed

12 July 2007 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 28 Dec 2006

4 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.